Liver Transplant Pathology in Pediatric Metabolic Disorders

Garrod AE . Inborn errors of metabolism (Croonian lectures). Lancet 1908;2:1,73,142,214.

Burdelski M , Rodeck B , Latta A , Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis 1991;14:604–618.

Mowat AP . Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr 1992;151 (Suppl 1):S32–S38.

Kelly DA . Organ transplantation for inherited metabolic disease. Arch Dis Child 1994;71:181–183.

Rela M , Muiesan P , Heaton ND , Orthotopic liver transplantation for hepatic-based metabolic disorders. Transplant Int 1995;8:41–44.

Phaneuf D , Labelle Y , Berube D , Cloning and expression of the cDNA endocoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignments of the gene to chromosome 15. Am J Hum Genet 1991;48:525–535.

Rootwelt H , Hoie K , Berger R , Kvittingen EA . Fumarylace-toacetate mutations in tyrosinemia type 1. Hum Mutat 1996;7:239–243.

Lindstedt S , Holme E , Lock E , Hjalmarson O , Strandvik B. Treatment of hereditary tyrosinemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340: 813–817.

Kvittingen EA , Rootwelt H , Brantzaeg D , Bergan A , Berger R. Self-induced correction of the hereditary tyrosinemia type 1 fumarylacetoacetase defect in tyrosinemia type 1. J Clin Invest 1993;91:1816–1821.

Paradis K , Weber A , Seidman EG , Liver transplantation for hereditary tyrosinemia: the Quebec experience. Am J Hum Genet 1990;47:338–342.

Bruneau N , St-Vil D , Luks FI , LaBerge JM , Bensoussan AL , Blanchard H. Surgical and metabolic aspects of liver transplantation for tyrosinemia. Ann Chir 1993;47:803–809 (in French).

Mieles LA , Esquivel CO , Van Thiel DH , Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh. Digest Dis Sci 1990;35:153–157.

Laine J , Salo MK , Krogerus L , Karkainen J , Wahlroos O , Holmberg C. The nephropathy of type 1 tyrosinemia after liver transplantation. Pediatr Res 1995;37:640–645.

Shoemaker LR , Strife CF , Balistreri WF , Ryckman FC . Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement. Pediatrics 1992;89:251–255.

Tuchman M , Freese DK , Sharp HL , Ramnaraine ML , Ascher N , Bloomer JR . Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type 1: study of those patients after liver transplantation. J Pediatr 1987;110:399–403.

Paradis K. Tyrosinemia: the Quebec experience. Clin Invest Med 1996;19:311–316.

Gans H , Sharp HL , Tan BH . Antiprotease deficiency and familial infantile liver cirrhosis. Surg Gynec Obstet 1969; 129:289–299.

Sharp HL , Bridges RA , Krivit W , Freier EF . Cirrhosis associated with α-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969;73:934–939.

Sveger T. Liver disease in α-1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316–1321.

Sveger T. The natural history of liver disease in α-1-antitrypsin deficient children. Acta Pediatr Scand 1988;77:847–851.

Wu Y , Whitman I , Molmenti E , Moore K , Hippenmeyer P , Perlmutter DH . Lag in intracellular degradation of mutant α-1-antitrypsin correlates with the liver disease phenotype in homozygous PIZZ α-1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:901–904.

Filipponi F , Soubrane O , Labrousse F , Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation. J Hepatol 1994;20:72–78.

Hood JM , Koep L , Peters RF , Liver transplantation for advanced liver disease with α-1-antitrypsin deficiency. N Engl J Med 1980;302:272–276.

Perlmutter DH . The cellular basis for liver injury in α-1-antitrypsin deficiency. Hepatology 1991;13:172–185.

Perlmutter DH , May LT , Sehgal PB . Interferon B2/interleukin-6 modulates synthesis of α-1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest 1989;84:138–144.

Wewers M , Casolaro A , Sellers SL , Replacement therapy for α-1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055–1062.

Crystal RG . Alpha-1-antitrypsin deficiency, emphysema and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990;85:1343–1352.

Maier-Dobersberger T , Mannhalter C , Rack S , Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995;109:2005–2008.

Bellary S , Hassanein T , van Thiel DH . Liver transplantation in Wilson's disease. J Hepatol 1995;23:373–381.

Song HS , Ku WC , Chen CL . Disappearance of Kayser-Fleischer rings following liver transplantation. Transplant Proc 1992;24:1483–1485.

Schilsky ML , Scheinberg IH , Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583–587.

Portmann B , Mowat AP . Copper-associated liver disease in childhood. J Hepatol 1995;23:538–543.

Adamson M , Reiner B , Olson JL , Indian childhood cirrhosis in an American child. Gastroenterology 1992;102:1771–1777.

Hahn SH , Tanner MS , Danks DM , Gahl MA . Normal metallothionein synthesis in fibroblasts obtained from children with Indian childhood cirrhosis or copper-associated childhood cirrhosis. Biochem Molec Med 1995; 54:142–145.

Knisely AS , Magid MS , Dische MR , Cutz E. Neonatal hemochromatosis. Birth Defects Orig Art Ser 1987;23:75–102.

Knisely AS . Neonatal hemochromatosis. Adv Pediatr 1992; 39:383–403.

Jonas MM , Kaweblum YA , Fojaco R. Neonatal hemochromatosis: failure of deferoxamine therapy. J Pediatr Gastroenterol Nutr 1987;6:984–988.

Silver MM , Cave CT , Kirpalani H. Perinatal hemochromatosis. Pediatr Pathol 1989;9:203–210.

Egawa H , Berquist W , Garcia-Kennedy R , Cox K , Knisely AS , Esquivel CO . Rapid development of hepatocellular siderosis after liver transplantation for neonatal hemochromatosis. Transplantation 1996;62:1511–1513.

Rand EB , McClenathan DT , Whitington PF . Neonatal hemochromatosis: report of successful orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1992;15:325–329.

Lund DP , Lillehei CW , Kevy S , Liver transplantation in newborn liver failure: treatment for neonatal hemochromatosis. Transplant Proc 1993;25:1068–1071.

Muiesan P Rela M , Kane P Liver transplantation for neonatal haemochromatosis. Arch Dis Child 1995;73:F178–F180.

Sigurdsson L , Reyes J , Kocoshis S , Hansen TWR , Rosh J , Knisely AS . Neonatal hemochromatosis: therapy and outcome. J Pediatr Gastroenterol Nutr 1998;26:in press.

Jazwinska EC , Powel LW . Hemochromatosis and HLA-H; definite. Hepatology 1997;24:495–496.

Deugnier Y , Turlin B , le Quilleuc D , A reappraisal of hepatic siderosis in patents with end stage cirrhosis. Practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;21:669–675.

Thon VJ , Khalil M , Cannon JF . Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast. J Biol Chem 1993;268:7509–7513.

McConkie-Rosell A , Wilson C , Picolli DA , Clinical and laboratory findings in four patients with the nonprogressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 1996;19:51–58.

Bao Y , Kishnani P , Wu T-Y , Chen YT . Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 1996;97:941–948.

Selby R , Starzl TE , Yunis E , Liver transplantation for type IV glycogen storage disease. N Engl J Med 1991;324:39–42.

Starzl TE , Demetris AJ , Trucco M , Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher's disease. N Engl J Med 1993;328:745–749.

Sokal EM , Van Hoof F , Alberti D , de Ville de Goyet J , de Barsy T , Otte JB . Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur J Pediatr 1992;151:200–203.

Purdue PE , Lumb MJ , Allsop J , Danpure CD . An intronic duplication in the alamine:glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygous patients with primary hyperoxaluria type 1. Hum Genet 1991;87:394–396.

Klauwers J , Wolf PL , Cohn R. Renal transplantation in primary oxalosis. JAMA 1969;209:551.

Watts RW , Calne RY , Williams R , Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation. Q J Med 1985;57:697–703.

Latta K , Brodehl J. Primary hyperoxaluria type I. Eur J Pediatr 1990;149:518–522.

Watts RW , Danpure CJ , DePauw L. Combined liver-kidney and isolated liver transplantation for primary hyperoxaluria type I. The European experience. The European Study Group on Transplantation in Hyperoxaluria Type I. Nephrol Dial Transplant 1991;6:502–511.

Cochat P , Scharer K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type I. Pediatr Nephrol 1993;7:212–218; discussion, 218–219.

Tripp JH , Hargreaves T , Anthony PP , Sodium valproate and ornithine carbamyl transferase deficiency [Letter]. Lancet 1981;1:1165–1166.

Honeycutt D , Callahan K , Rutledge L , Evans B. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Neurology 1992;42:666–668.

Batshaw ML . Inborn errors of urea synthesis. Ann Neurol 1994;35:133–141.

Hasegawa T , Tzakis AG , Todo S , Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995;30:863–865.

Hoshide R , Soejima H , Ohta T , Assignment of the human carbamylphosphate synthetase 1 gene (CPS1) to 2q35 by fluorescence in situ hybridization. Genomics 1995;28:124–125.

Jan D , Laurent J , Lacaille F , Liver transplantation in children with inherited metabolic disorders. Transplant Proc 1995;27:1706–1707.

Hoeg JN , Starzl TE , Brewer HB Jr. Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. Am J Cardiol 1987;59:705–707.

Valdivielso P , Escolar JL , Cuervas-Mons V , Pulpon LA , Chaparro MA , Gonzalez-Santos P. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Int Med 1988;108:204–206.

Bilheimer DW . Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis 1989;9: Suppl 1, I:158–163.

East C , Grundy SM , Bilheimer DW . Normal cholesterol levels with lovastatin (Mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. JAMA 1986;256:2843–2848.

Sokal EM , Ulla L , Harvengt C , Otte JB . Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 1993;55:432–433.

Kraft HG , Menzel HJ , Hoppichler F , Vogel W , Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 1989;83:137–142.

Linton MF , Gish R , Hubl ST , Phenotypes of apolipo-protein B and apolipoprotein E after liver transplantation. J Clin Invest 1991;88:270–281.

Bontempo FA , Lewis JH , Gorenc TJ , Liver transplantation in hemophilia A. Blood 1987;69:1721–1724.

Stringer MD , Melissari E , Kakker VV , Tan KC . Protein C deficiency and thrombotic complications after liver transplantation in children. Lancet 1989;1:102–103.

Carlson DE , Busuttil RW , Giudici TA , Barranger JA . Ortho-topic liver transplantation in the treatment of complications of type I Gaucher disease. Transplantation 1990;49:1192–1194.

Smanik EJ , Tavill AS , Jacobs GH , Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic disease. Hepatology 1993;17:42–49.

Carstea ED , Morris JA , Coleman KG . Niemann-Pick C1 disease gene. Homology to mediators of cholesterol homeostasis. Science 1997;277:228–231.

Gartner JC , Bergman I , Malatack JJ , Progressive neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics 1986;77:104–106.

DuCerf C , Bancel B , Caillon P , Orthotopic liver transplantation for type I Gaucher's disease. Transplantation 1992;53:1141–1143.

Jonas AJ , Smith ML , Schneider IA . ATP-dependent lysosomal cystine reflux is defective in cystinosis. J Biol Chem 1982;257:13185–13188.

Klenn PJ , Rubin R. Hepatic fibrosis associated with hereditary cystinosis: a novel from of noncirrhotic portal hypertension. Mod Pathol 1994;7:879–882.

Avner ED , Ellis D , Jaffe R. Veno-occlusive disease of the liver associated with cysteamine treatment of nephropathic cystinosis. J Pediatr 1983;102:793–796.

Morton KO , Schneider F , Weimer MK , Straka JG , Bloomer JR . Hepatic and bile porphyria in patients with protoporphyria and liver failure. Gastroenterology 1988;94:1488–1492.

Sheth AP , Esterley NB , Rabinowitz LG , Poh-Fitzpatrick MB . Cutaneous porphyria-like photosensitivity after liver transplantation. Arch Dermatol 1994;130:616–617.

Samuel D , Boboc B , Bernuau J , Bismith H , Benhamou JP . Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyria overproduction. Gastroenterology 1988;95:816–819.

Mion FB , Faure JL , Berger F , McGregor B , Perrot H , Paliard P. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term followup. J Hepatol 1992;16:203–207.

Polson RJ , Lunn CK , Rolles K , Calne RY , Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation 1988;46:386–389.

Steinmuller T , Doss MO , Steffen R , Liver transplantation in erythropoietic protoporphyria. Deutch Mediz Wochenschr 1991;177:1097–1102 (in German).

De Torres I , Demetris AJ , Randhawa PS . Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 1996;61:1412–1413.

Starzl TE , Demetris AJ . Transplantation milestones viewed with one and two-way paradigms of tolerance. JAMA 1995;273:876–879.

Cransac M , Carles J , Bernard PH , Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transplant Int 1995;8:307–311.

Monaghan G , Ryan M , Seddon R , Hume R , Burchell B. Genetic variation in bilirubin UDP-gluconosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996;347:578–581.

Bosma PJ , Chowdry JR , Bakker C , The genetic basis of the reduced expression of bilirubin UDP-glucosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171–1175.

Henne-Bruns D , Kremer B. Manifestation of Gilbert syndrome (Meulengracht disease) following orthotopic liver transplantation: a rare cause of postoperative hyperbilirubinemia. Klin Wochenschr 1988;66:596–598 (in German).

Jansen PLM , Bosma PJ , Bakker C , Lems SPM , Slooh MJH , Haagsma EB . Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucomonosyltransferase gene promotor sequence in the donor. J Hepatol 1997;27:1–5.